16-30928546-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001382779.1(FBXL19):c.707C>T(p.Pro236Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000051 in 1,607,972 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001382779.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FBXL19 | NM_001382779.1 | c.707C>T | p.Pro236Leu | missense_variant | 6/11 | ENST00000338343.10 | NP_001369708.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FBXL19 | ENST00000338343.10 | c.707C>T | p.Pro236Leu | missense_variant | 6/11 | 5 | NM_001382779.1 | ENSP00000339712 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000151 AC: 23AN: 152146Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000336 AC: 8AN: 237948Hom.: 0 AF XY: 0.0000385 AC XY: 5AN XY: 129816
GnomAD4 exome AF: 0.0000405 AC: 59AN: 1455708Hom.: 0 Cov.: 32 AF XY: 0.0000428 AC XY: 31AN XY: 723944
GnomAD4 genome AF: 0.000151 AC: 23AN: 152264Hom.: 0 Cov.: 31 AF XY: 0.000161 AC XY: 12AN XY: 74436
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 04, 2023 | The c.767C>T (p.P256L) alteration is located in exon 6 (coding exon 6) of the FBXL19 gene. This alteration results from a C to T substitution at nucleotide position 767, causing the proline (P) at amino acid position 256 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at